Clinical trial · Observational
Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men
NCT02088164CI-TRIAL-00014033completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To determine the long-term survival outcome of subjects who had various PSA levels at screening
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Healthy men
- description
- Healthy men who received PSA screening
Primary outcomes (1)
- measure
- Diagnosis of prostate cancer
- timeFrame
- 20 years (average)
Secondary outcomes (2)
- measure
- Cancer-specific death
- timeFrame
- 20 years (average)
- measure
- Overall survival
- timeFrame
- 20 years (average)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 41 Years
Show eligibility criteria text
Inclusion Criteria: * Health men who received PSA screening at NTUH and CGMH Exclusion Criteria: * Prior history of prostate cancer
References
Publications (0)
Data not yet available
No reference posted for this study.